News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
769,908 Results
Type
Article (46702)
Company Profile (502)
Press Release (722690)
Multimedia
Podcasts (130)
Webinars (21)
Section
Business (217867)
Career Advice (2257)
Deals (38040)
Drug Delivery (131)
Drug Development (85430)
Employer Resources (176)
FDA (17077)
Job Trends (15629)
News (367444)
Policy (34552)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2730)
Accelerated approval (41)
Adcomms (31)
Allergies (159)
Alliances (52810)
ALS (190)
Alzheimer's disease (1760)
Antibody-drug conjugate (ADC) (362)
Approvals (17327)
Artificial intelligence (629)
Autoimmune disease (194)
Automation (45)
Bankruptcy (389)
Best Places to Work (11995)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (350)
Bladder cancer (173)
Brain cancer (66)
Breast cancer (683)
Cancer (5232)
Cardiovascular disease (452)
Career advice (1915)
Career pathing (42)
CAR-T (302)
CDC (54)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (39)
Clinical research (72938)
Collaboration (1920)
Company closure (4)
Compensation (1245)
Complete response letters (74)
COVID-19 (2820)
CRISPR (107)
C-suite (961)
Cystic fibrosis (155)
Data (6719)
Decentralized trials (2)
Denatured (42)
Depression (157)
Diabetes (525)
Diagnostics (6988)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (310)
Drug pricing (205)
Drug shortages (30)
Duchenne muscular dystrophy (265)
Earnings (96334)
Editorial (63)
Employer branding (22)
Employer resources (156)
Events (126892)
Executive appointments (1050)
FDA (20399)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1612)
Gene editing (229)
Generative AI (54)
Gene therapy (694)
GLP-1 (1073)
Government (4873)
Grass and pollen (6)
Guidances (387)
Healthcare (19672)
HIV (73)
Huntington's disease (53)
IgA nephropathy (90)
Immunology and inflammation (289)
Immuno-oncology (72)
Indications (137)
Infectious disease (3117)
Inflammatory bowel disease (211)
Inflation Reduction Act (17)
Influenza (129)
Intellectual property (266)
Interviews (355)
IPO (17327)
IRA (54)
Job creations (3996)
Job search strategy (1600)
JPM (67)
Kidney cancer (18)
Labor market (89)
Layoffs (601)
Leadership (37)
Legal (8531)
Liver cancer (97)
Longevity (21)
Lung cancer (699)
Lymphoma (394)
Machine learning (47)
Management (61)
Manufacturing (884)
MASH (179)
Medical device (14341)
Medtech (14407)
Mergers & acquisitions (21840)
Metabolic disorders (1402)
mRNA (188)
Multiple sclerosis (177)
NASH (20)
Neurodegenerative disease (368)
Neuropsychiatric disorders (103)
Neuroscience (3150)
Neurotech (1)
NextGen: Class of 2026 (6994)
Non-profit (4685)
Now hiring (69)
Obesity (679)
Opinion (309)
Ovarian cancer (174)
Pain (223)
Pancreatic cancer (251)
Parkinson's disease (316)
Partnered (34)
Patents (535)
Patient recruitment (555)
Peanut (62)
People (62430)
Pharmaceutical (92)
Pharmacy benefit managers (32)
Phase 1 (22860)
Phase 2 (32034)
Phase 3 (23863)
Pipeline (6242)
Policy (314)
Postmarket research (2717)
Preclinical (9784)
Press Release (70)
Prostate cancer (270)
Psychedelics (57)
Radiopharmaceuticals (314)
Rare diseases (992)
Real estate (6355)
Recruiting (71)
Regulatory (25960)
Reports (54)
Research institute (2545)
Resumes & cover letters (383)
Rett syndrome (30)
RNA editing (21)
RSV (82)
Schizophrenia (163)
Series A (273)
Series B (205)
Service/supplier (12)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (165)
Sponsored (43)
Startups (3916)
State (2)
Stomach cancer (19)
Supply chain (115)
Tariffs (85)
The Weekly (86)
Vaccines (1077)
Venture capital (99)
Weight loss (443)
Women's health (105)
Worklife (20)
Date
Today (191)
Last 7 days (755)
Last 30 days (3071)
Last 365 days (31555)
2026 (6030)
2025 (31922)
2024 (36958)
2023 (41487)
2022 (52845)
2021 (57464)
2020 (55763)
2019 (48489)
2018 (36634)
2017 (33859)
2016 (33573)
2015 (39735)
2014 (33928)
2013 (28917)
2012 (31034)
2011 (31753)
2010 (30170)
Location
Africa (822)
Alabama (92)
Alaska (7)
Arizona (335)
Arkansas (15)
Asia (42503)
Australia (7032)
California (12145)
Canada (3440)
China (1201)
Colorado (509)
Connecticut (528)
Delaware (356)
Europe (94001)
Florida (1798)
Georgia (381)
Hawaii (3)
Idaho (65)
Illinois (950)
India (76)
Indiana (552)
Iowa (24)
Japan (466)
Kansas (131)
Kentucky (47)
Louisiana (35)
Maine (85)
Maryland (1466)
Massachusetts (8889)
Michigan (363)
Minnesota (672)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (133)
New Hampshire (87)
New Jersey (3234)
New Mexico (32)
New York (3177)
North Carolina (1610)
North Dakota (10)
Northern California (5942)
Ohio (360)
Oklahoma (21)
Oregon (46)
Pennsylvania (2416)
Puerto Rico (24)
Rhode Island (51)
South America (1211)
South Carolina (70)
South Dakota (1)
Southern California (4725)
Tennessee (193)
Texas (1880)
United States (43259)
Utah (364)
Vermont (1)
Virginia (287)
Washington D.C. (84)
Washington State (992)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
769,908 Results for "curagen corporation acquired by celldex therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
February 26, 2026
·
11 min read
Press Releases
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
March 9, 2026
·
9 min read
Press Releases
Celldex to Present at Upcoming Investor Conferences - February 9, 2026
February 9, 2026
·
1 min read
Press Releases
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025
·
13 min read
Press Releases
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab’s First-in-Class and Best-in-Disease Profile
February 23, 2026
·
5 min read
Press Releases
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
February 25, 2026
·
7 min read
Press Releases
Celldex to Present at Upcoming Investor Conferences
November 10, 2025
·
1 min read
Press Releases
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
November 11, 2025
·
5 min read
Press Releases
Danaher To Acquire Masimo Corporation
February 17, 2026
·
15 min read
Press Releases
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
December 10, 2025
·
9 min read
1 of 76,991
Next
